KIF1A-associated neurological disorder: Year of the Zebra

Last updated: November 28, 2023

KIF1A-associated neurological disorder: Year of the Zebra

E Respi

E Respi

Upper respiratory tract infection
Upper respiratory tract infections: Clinical sciences
Rhinovirus
Anatomy of the nose and paranasal sinuses
Sinusitis
Streptococcus pneumoniae
Nasal, oral and pharyngeal diseases: Pathology review
Anatomy of the external and middle ear
Anatomy clinical correlates: Ear
Otitis media
Otitis media and externa (pediatrics): Clinical sciences
Haemophilus influenzae
Moraxella catarrhalis
Streptococcus pyogenes (Group A Strep)
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
KIF1A-associated neurological disorder: Year of the Zebra
Poststreptococcal glomerulonephritis
Coxsackievirus
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Epstein-Barr virus (Infectious mononucleosis)
Adenovirus
Retropharyngeal and peritonsillar abscesses
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Croup
Human parainfluenza viruses
Croup and epiglottitis: Clinical sciences
Respiratory syncytial virus
Bronchiolitis: Clinical sciences
Immunizations (adult): Clinical sciences
Influenza virus
Neuraminidase inhibitors
Influenza: Clinical sciences
The flu vaccine: Information for patients and families
COVID-19: Clinical sciences
Obstructive lung diseases: Pathology review
Asthma
Asthma: Clinical sciences
Tobacco use disorder
Tobacco use: Clinical sciences
Approach to a cough (acute): Clinical sciences
Approach to a cough (subacute and chronic): Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to chest pain: Clinical sciences
Approach to a fever: Clinical sciences
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Tuberculosis (pulmonary): Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Antituberculosis medications
Cystic fibrosis: Pathology review
Cystic fibrosis
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Reading a chest X-ray
Chest X-ray interpretation: Clinical sciences
Pneumocystis jirovecii (Pneumocystis pneumonia)
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome
Acute respiratory distress syndrome: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Deep vein thrombosis and pulmonary embolism: Pathology review
Pulmonary embolism
Pulmonary embolism: Clinical sciences

Transcript

Watch video only

KIF1A-associated neurological disorder, or KAND for short, is a group of rare genetic conditions that result in progressive neurological dysfunction due to alterations in the KIF1A gene. The KIF1A gene codes for a specialized protein called kinesin found in neurons. Kinesin helps transport nutrients and other important molecules along the neuron’s axon, like a minecart on a railway track.

Alterations affecting the KIF1A gene lead to faulty kinesin that either stops or slows down axonal transport, resulting in neuronal dysfunction and even cell death.

So far, researchers have identified over 100 alterations affecting the KIF1A gene. These alterations can be inherited in autosomal dominant or recessive patterns, however, the most common and most severe forms are caused by de novo alterations, meaning they arise spontaneously and are not inherited.

Now, KAND is a spectrum-type condition, meaning the symptoms and progression vary greatly from one individual to another depending on the underlying gene alteration and pattern of inheritance.

One of the main features is spastic paraplegia, a condition where muscle weakness and stiffness in the legs causes the individual’s movements to jerk, affecting their ability to walk and move around.

Some children may also have a delay in reaching childhood milestones, like walking and talking, and they may experience difficulty with coordination and balance; as well as seizures and visual disturbances. Additionally, because brain development can be affected, individuals may have microcephaly, which is when head size is smaller than expected for an individual’s age.

Certain alterations in the KIF1A gene cause damage to sensory nerves, resulting in numbness and a tingling or burning sensation in the hands or feet. Less frequently, individuals may have dysfunction of the autonomic nerves that control involuntary bodily functions, like body temperature. As a result, individuals with KAND may have unexplained episodes of fever, which may be mistaken for having an infection.

Sources

  1. "Axonal transport and neurological disease. " Nat Rev Neurol (2019;15(12):691-703)
  2. "KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia. " Eur J Hum Genet (2020;28(1):40-49)
  3. "Phenotypic expansion in KIF1A ‐related dominant disorders: A description of novel variants and review of published cases. " Hum Mutat (2020;41(12):2094-2104)
  4. "KIF1A-associated neurological disorder: An overview of a rare mutational disease. " Pharmaceuticals (Basel) (2023;16(2):147)